# Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris

> **NCT01885156** · PHASE3 · COMPLETED · sponsor: **Merz North America, Inc.** · enrollment: 65 (actual)

## Conditions studied

- Tinea Cruris
- Jock Itch

## Interventions

- **DRUG:** Naftin 1% Cream
- **DRUG:** Placebo Cream

## Key facts

- **NCT ID:** NCT01885156
- **Lead sponsor:** Merz North America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2015-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01885156

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01885156, "Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01885156. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*